http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015011598-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_078cb8366425c7f7bb46338421d23406
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4035
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4035
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4184
filingDate 2012-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19ae5d848b42b55b098d0be2ff20fbd3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3541f9dd47d051210b6ae1acb13e32c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce61b231cb06d959719f627fd652165e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b28c63ff270c9e085626b2976c071d5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c302db5ca5366473b0754e9da3d05918
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f1bae204d6935bda54c8bb7d0397807
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6403ebc5707697c904abdee4f416b2d1
publicationDate 2015-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2015011598-A1
titleOfInvention Pharmaceutical composition comprising candesartan or ester thereof and chlortalidone, and use thereof
abstract Provided is a pharmaceutical composition comprising candesartan or ester thereof and chlorthalidone, and use thereof, wherein the weight ratio of candesartan or ester thereof to chlorthalidone is 5.3:1 to 1:6.25. The pharmaceutical composition has a synergistic antihypertensive effect, and can enhance the antihypertensive effect and extend duration of antihypertension.
priorityDate 2011-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011008428-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007160665-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010204252-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5250548-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2540
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID327884382
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2541
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2162
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54515534
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400285
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129815624
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400268
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226425988
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5362119
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394001
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129144708
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414324
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414137
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3639
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10351092
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405997
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2732
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID58370375
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410822407
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID172198
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396025

Total number of triples: 46.